| Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised … RM Anthenelli, NL Benowitz, R West, L St Aubin, T McRae, D Lawrence, ... The Lancet 387 (10037), 2507-2520, 2016 | 980 | 2016 |
| Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: a review ND Volkow, JM Swanson, AE Evins, LE DeLisi, MH Meier, R Gonzalez, ... JAMA psychiatry 73 (3), 292-297, 2016 | 827 | 2016 |
| Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis DC Henderson, E Cagliero, PM Copeland, CP Borba, AE Evins, ... Archives of general psychiatry 62 (1), 19-28, 2005 | 496 | 2005 |
| The problem of the placebo response in clinical trials for psychiatric disorders: culprits, possible remedies, and a novel study design approach M Fava, AE Evins, DJ Dorer, DA Schoenfeld Psychotherapy and psychosomatics 72 (3), 115-127, 2003 | 482 | 2003 |
| Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence AC Janes, DA Pizzagalli, S Richardt, BB Frederick, S Chuzi, G Pachas, ... Biological psychiatry 67 (8), 722-729, 2010 | 454 | 2010 |
| Medical morbidity and mortality in schizophrenia: guidelines for psychiatrists. DC Goff, C Cather, AE Evins, DC Henderson, O Freudenreich, ... Journal of Clinical Psychiatry 66 (2), 183-194, 2005 | 439 | 2005 |
| The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls RS Barr, MA Culhane, LE Jubelt, RS Mufti, MA Dyer, AP Weiss, ... Neuropsychopharmacology 33 (3), 480-490, 2008 | 303 | 2008 |
| Single dose of a dopamine agonist impairs reinforcement learning in humans: behavioral evidence from a laboratory-based measure of reward responsiveness DA Pizzagalli, AE Evins, EC Schetter, MJ Frank, PE Pajtas, DL Santesso, ... Psychopharmacology 196, 221-232, 2008 | 294 | 2008 |
| Clozapine, diabetes mellitus, hyperlipidemia, and cardiovascular risks and mortality: results of a 10-year naturalistic study DC Henderson, DD Nguyen, PM Copeland, DL Hayden, CP Borba, ... Journal of Clinical Psychiatry 66 (9), 1116-1121, 2005 | 256 | 2005 |
| A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia AE Evins, VK Mays, C Cather, DC Goff, NA Rigotti, T Tisdale Nicotine & tobacco research 3 (4), 397-403, 2001 | 254 | 2001 |
| Optimizing real time fMRI neurofeedback for therapeutic discovery and development LE Stoeckel, KA Garrison, SS Ghosh, P Wighton, CA Hanlon, JM Gilman, ... NeuroImage: Clinical 5, 245-255, 2014 | 250 | 2014 |
| A double-blind placebo-controlled trial of bupropion sustained-release for smoking cessation in schizophrenia AE Evins, C Cather, T Deckersbach, O Freudenreich, MA Culhane, ... Journal of clinical psychopharmacology 25 (3), 218-225, 2005 | 250 | 2005 |
| Placebo-controlled trial of glycine added to clozapine in schizophrenia AE Evins, SM Fitzgerald, L Wine, R Rosselli, DC Goff American Journal of Psychiatry 157 (5), 826-828, 2000 | 245 | 2000 |
| A placebo-controlled crossover trial of D-cycloserine added to clozapine in patients with schizophrenia DC Goff, DC Henderson, AE Evins, E Amico Biological psychiatry 45 (4), 512-514, 1999 | 232 | 1999 |
| Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial AE Evins, C Cather, SA Pratt, GN Pachas, SS Hoeppner, DC Goff, ... Jama 311 (2), 145-154, 2014 | 230 | 2014 |
| A 12-week double-blind, placebo-controlled study of bupropion sr added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia AE Evins, C Cather, MA Culhane, A Birnbaum, J Horowitz, E Hsieh, ... Journal of clinical psychopharmacology 27 (4), 380-386, 2007 | 207 | 2007 |
| Opioid antagonists for smoking cessation SP David, T Lancaster, LF Stead, AE Evins, JJ Prochaska Cochrane Database of Systematic Reviews, 2013 | 202 | 2013 |
| Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight O Freudenreich, C Cather, AE Evins, DC Henderson, DC Goff Journal of Clinical Psychiatry 65 (10), 1372-1376, 2004 | 194 | 2004 |
| Folate, homocysteine, and negative symptoms in schizophrenia DC Goff, T Bottiglieri, E Arning, V Shih, O Freudenreich, AE Evins, ... American Journal of Psychiatry 161 (9), 1705-1708, 2004 | 183 | 2004 |
| An exploratory open‐label trial of aripiprazole as an adjuvant to clozapine therapy in chronic schizophrenia DC Henderson, L Kunkel, DD Nguyen, CP Borba, TB Daley, PM Louie, ... Acta Psychiatrica Scandinavica 113 (2), 142-147, 2006 | 176 | 2006 |
Donald GoffNYU School of Medicine在 nyumc.org 的电子邮件经过验证
